Nexgel Inc
NXGL
查看详细走势图
1.620USD
-0.020-1.22%
收盘 12/19, 16:00（美东）报价延迟15分钟
13.19M总市值
亏损市盈率 TTM
盘中分时
1分
30分
1小时
日k
周k
月k
日k
今天
-1.22%
5天
-2.99%
1月
0.00%
6月
-31.36%
今年开始到现在
-63.68%
1年
-65.75%
查看详细走势图
TradingKey Nexgel Inc股票评分
单位: USD 更新时间: 2025-12-19操作建议
Nexgel Inc当前公司基本面数据相对稳定，增长潜力很大。当前估值合理，在药品行业排名91/158位。机构持股占比非常高，近一月多位分析师给出公司评级为买入。最高目标价6.00。中期看，股价处于下降通道。近一个月，市场表现一般，但公司基本面和技术面得分较高。目前股价在压力位和支撑位之间，可以做区间波段操作。
Nexgel Inc评分
压力支撑
由于公司未披露，未能获取相关数据
多维评测
本期评分
上期评分
分析师目标
根据
1
位分析师
买入
评级
6.000
目标均价
+308.16%
涨幅空间
数据免责声明：分析师评级与目标价由LSEG提供，仅供参考，不应当作投资建议
Nexgel Inc亮点
亮点风险
NexGel, Inc. is a provider of healthcare, beauty, and over-the-counter products, including ultra-gentle, high-water-content hydrogels. It is engaged in manufacturing high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. It specializes in custom gels by capitalizing on proprietary manufacturing technologies. The Company operates through two segments: NexGel and CGN. Its Nexgel segment comprises the manufacturing of ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, which is based in Langhorne, Pennsylvania. Its CGN segment comprises CG Converting and Packaging, LLC (CGN), a joint venture with C.G. Laboratories Inc. (CG Labs) used for the Company’s converting and packaging business, which is based in Granbury, Texas. Its brands include Silverseal, Hexagels, Turfguard, Kenkoderm, and Silly George.
业绩高增长
公司营业收入稳步增长，连续3年增长324.22%
业绩增长期
公司处于发展阶段，最新年度总收入8.69M美元
估值合理
公司最新PE估值-4.28，处于3年历史合理位
机构加仓
最新机构持股790.59K股，环比增加7.97%
詹姆斯·西蒙斯持仓
明星投资者詹姆斯·西蒙斯持仓，最新持仓市值63.45K
Nexgel Inc新闻
即将为您带来更多新闻，敬请期待。。。
财务指标
每股收益
由于公司未披露，未能获取相关数据
营业总收入
由于公司未披露，未能获取相关数据
Nexgel Inc简介
NexGel, Inc. is a provider of healthcare, beauty, and over-the-counter products, including ultra-gentle, high-water-content hydrogels. It is engaged in manufacturing high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. It specializes in custom gels by capitalizing on proprietary manufacturing technologies. The Company operates through two segments: NexGel and CGN. Its Nexgel segment comprises the manufacturing of ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, which is based in Langhorne, Pennsylvania. Its CGN segment comprises CG Converting and Packaging, LLC (CGN), a joint venture with C.G. Laboratories Inc. (CG Labs) used for the Company’s converting and packaging business, which is based in Granbury, Texas. Its brands include Silverseal, Hexagels, Turfguard, Kenkoderm, and Silly George.
公司代码NXGL
公司Nexgel Inc
CEOLevy (Adam)
网址https://nexgel.com/
常见问题
Nexgel Inc(NXGL)的当前股价是多少？
Nexgel Inc(NXGL)的当前股价是 1.620。
Nexgel Inc的股票代码是什么？
Nexgel Inc的股票代码是NXGL。
Nexgel Inc股票的52周最高点是多少？
Nexgel Inc股票的52周最高点是4.950。
Nexgel Inc股票的52周最低点是多少？
Nexgel Inc股票的52周最低点是1.450。
Nexgel Inc的市值是多少？
Nexgel Inc的市值是13.19M。
Nexgel Inc的净利润是多少？
Nexgel Inc的净利润为-3.28M。
现在Nexgel Inc(NXGL)的股票是买入、持有还是卖出？
根据分析师评级，Nexgel Inc(NXGL)的总体评级为买入，目标价格为6.000。
Nexgel Inc(NXGL)股票的每股收益（EPS TTM）是多少
Nexgel Inc(NXGL)股票的每股收益（EPS TTM）是-0.378。
相关品种
